These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 37352455)

  • 1. Use of camouflage in vitiligo: A cross-sectional survey.
    Poondru S; Kundu RV
    J Cosmet Dermatol; 2023 Dec; 22(12):3524-3526. PubMed ID: 37352455
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of Cosmetic Camouflage in Adults With Vitiligo.
    Morales-Sánchez MA; Laguna-Meraz JP; Peralta-Pedrero ML; Jurado-Santa Cruz F
    Actas Dermosifiliogr; 2022 Mar; 113(3):316-318. PubMed ID: 35526927
    [No Abstract]   [Full Text] [Related]  

  • 3. Camouflage therapy workshop for pediatric dermatology patients: a review of 6 cases.
    Padilla-España L; del Boz J; Ramírez-López MB; Fernández-Sánchez ME
    Actas Dermosifiliogr; 2014 Jun; 105(5):510-4. PubMed ID: 24369988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Camouflage for patients with vitiligo.
    Kaliyadan F; Kumar A
    Indian J Dermatol Venereol Leprol; 2012; 78(1):8-15. PubMed ID: 22199054
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cosmetic camouflage as an adjuvant to vitiligo therapies: Effect on quality of life.
    Bassiouny D; Hegazy R; Esmat S; Gawdat HI; Ahmed Ezzat M; Tawfik HA; Hegazy AA; Ibrahim S
    J Cosmet Dermatol; 2021 Jan; 20(1):159-165. PubMed ID: 32406129
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Camouflage for patients with vitiligo vulgaris improved their quality of life.
    Tanioka M; Yamamoto Y; Kato M; Miyachi Y
    J Cosmet Dermatol; 2010 Mar; 9(1):72-5. PubMed ID: 20367677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Camouflaging Agents for Vitiligo Patients.
    Hossain C; Porto DA; Hamzavi I; Lim HW
    J Drugs Dermatol; 2016 Apr; 15(4):384-7. PubMed ID: 27050692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lack of diversity in vitiligo clinical trials: a cross-sectional analysis.
    Hernandez LE; Verling S; Nouri K
    Arch Dermatol Res; 2023 Nov; 315(9):2735-2736. PubMed ID: 37486414
    [No Abstract]   [Full Text] [Related]  

  • 9. Camouflage for vitiligo.
    Tanioka M; Miyachi Y
    Dermatol Ther; 2009; 22(1):90-3. PubMed ID: 19222521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Views and Beliefs of Vitiligo Patients in Online Discussion Forums: A Qualitative Study.
    Gadarowski MB; Bashyam AM; McMichael AJ; Feldman SR
    Cutis; 2022 Jan; 109(1):49-53. PubMed ID: 35180057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessing the trends of outcome measures and quality of life instruments in vitiligo: A systematic review.
    Maghfour J; Shoukfeh R; Hamzavi IH; Ezzedine K; Mohammad TF
    J Eur Acad Dermatol Venereol; 2023 Nov; 37(11):2270-2272. PubMed ID: 37566732
    [No Abstract]   [Full Text] [Related]  

  • 12. Vitiligo: An Updated Narrative Review.
    Leung AKC; Lam JM; Leong KF; Hon KL
    Curr Pediatr Rev; 2021; 17(2):76-91. PubMed ID: 33302860
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the potential interference of camouflage on the treatment of vitiligo: An observer-blinded self-controlled study.
    Li M; Wang F; Ding X; Xu Q; Du J
    Dermatol Ther; 2021 Jan; 34(1):e14545. PubMed ID: 33190372
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Usefulness of corrective make-up in children with vitiligo coordinated by dermatology nursing].
    Padilla-España L; Ramírez-López B; Fernández-Sánchez E
    Enferm Clin; 2014; 24(3):196-9. PubMed ID: 24731391
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel three dimensional imaging method for the measurement of area in vitiligo and chemical leukoderma.
    Hayashi M; Okamura K; Araki Y; Suzuki M; Tanaka T; Abe Y; Nakano S; Yoshizawa J; Hozumi Y; Inoie M; Suzuki T
    J Dermatol Sci; 2016 Nov; 84(2):219-221. PubMed ID: 27576766
    [No Abstract]   [Full Text] [Related]  

  • 16. The contribution of skin camouflage volunteers in the management of vitiligo.
    Ekwegh U
    BMJ Case Rep; 2011 Nov; 2011():. PubMed ID: 22674598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Psychological comorbidities of vitiligo: a retrospective cross-sectional analysis in an urban population.
    Montgomery SN; Syder N; Barajas G; Elbuluk N
    Arch Dermatol Res; 2023 Dec; 316(1):14. PubMed ID: 38047925
    [No Abstract]   [Full Text] [Related]  

  • 18. Camouflage of Vitiligo by Medical Tattooing.
    Moreno A
    Curr Probl Dermatol; 2022; 56():187-196. PubMed ID: 37263205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Camouflaging vitiligo with dihydroxyacetone.
    Hsu S
    Dermatol Online J; 2008 Aug; 14(8):23. PubMed ID: 19061581
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quality of life and stigmatization profile in a cohort of vitiligo patients and effect of the use of camouflage.
    Ongenae K; Dierckxsens L; Brochez L; van Geel N; Naeyaert JM
    Dermatology; 2005; 210(4):279-85. PubMed ID: 15942213
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.